iSpecimen Inc. (ISPC)

CIK 0001558569 · Nasdaq · Services-Commercial Physical & Biological Research

Sector Services
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, iSpecimen Inc. reported revenue of $1.93M. Revenue fell 79.2% from the prior annual period.

Key ratios (year ended 2025-12-31)

-465.4%

Operating margin

-543.7%

Net margin

-339.6%

Return on year-end equity

-79.2%

Revenue growth (YoY)

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Revenue	$1.93M	$9.29M	$9.93M	—	—	—	—
Cost of Revenue	$1.90M	$5.30M	$4.82M	$4.76M	$5.25M	$3.59M	—
Operating Income	-$8.98M	-$12.73M	-$11.17M	-$10.19M	-$5.93M	-$2.41M	—
Net Income	-$10.49M	-$12.50M	-$11.10M	-$10.25M	-$8.96M	-$4.65M	—
EPS (Diluted)	$-2.28	$-17.58	$-24.55	$-1.16	$-2.09	$-4.97	—
Total Assets	$9.53M	$9.35M	$15.82M	$24.62M	$35.72M	$6.21M	—
Total Liabilities	$6.44M	$6.04M	$6.08M	$4.31M	$5.93M	$22.31M	—
Shareholders' Equity	$3.09M	$3.31M	$9.74M	$20.31M	$29.79M	-$27.28M	-$22.72M
Cash & Equivalents	$6.88M	$1.88M	$2.34M	$15.31M	$27.74M	$695.9K	—
Operating Cash Flow	-$4.24M	-$8.26M	-$5.81M	-$5.82M	-$10.67M	-$288.4K	—
Capital Expenditures	$454	$31.5K	$19.5K	$215.5K	$2.5K	$426	—
Shares Outstanding	8.48M	1.70M	454.2K	8.93M	8.73M	936.2K	—
Weighted Average Diluted Shares	4.60M	710.9K	452.1K	8.84M	4.29M	936.2K	—
EPS (Basic)	$-2.28	$-17.58	$-24.55	$-1.16	$-2.09	$-4.97	—